JCM
SAGE

Janney Capital Management’s Sage Therapeutics SAGE Stock Holding History

Janney Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,389
Closed -$363K – 210
2021
Q2 		$363K Buy
6,389
+27
+0.4% +$1.91K 0.02% 167
2021
Q1 		$476K Buy
6,362
+32
+0.5% +$2.62K 0.03% 142
2020
Q4 		$548K Sell
6,330
-49
-0.8% -$3.61K 0.04% 132
2020
Q3 		$390K Buy
+6,379
New +$323K 0.03% 152
2019
Q4 		– Sell
-4,255
Closed -$597K – 210
2019
Q3 		$597K Sell
4,255
-132
-3% -$22.1K 0.03% 126
2019
Q2 		$803K Buy
4,387
+675
+18% +$115K 0.04% 106
2019
Q1 		$590K Buy
3,712
+309
+9% +$44.7K 0.03% 124
2018
Q4 		$326K Buy
3,403
+558
+20% +$63.9K 0.02% 151
2018
Q3 		$402K Buy
+2,845
New +$439K 0.02% 166

Other funds holding SAGE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Janney Capital Management's SAGE Position: Q3 2021 in Review

Janney Capital Management sold out of Sage Therapeutics (SAGE) in Q3 2021, closing a stake of 6,389 shares — an estimated $363K sold.

Janney Capital Management first reported a position in SAGE in Q3 2018 and held it in 9 quarters. The position peaked at $803K in Q2 2019. 225 funds tracked by Wall St. Rank hold SAGE as of Q3 2021.

  • Janney Capital Management reported no remaining Sage Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Janney Capital Management sold 6,389 Sage Therapeutics shares in Q3 2021, an estimated $363K.
  • Janney Capital Management first reported a position in Sage Therapeutics in Q3 2018 and held it in 9 quarters.
  • Janney Capital Management's Sage Therapeutics position peaked at $803K in Q2 2019.
  • 225 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2021.

Based on Janney Capital Management's 13F filing for Q3 2021, filed 1 Nov 2021.